Pentapharm Ltd. has been sold to the DSM Group. After nearly 60 years in business, both the Stürm and the Percs family have decided to sell 100% of the stocks to the DSM Group.
According to the company, DSM intends to continue the strategic direction Caspar Stürm, CEO of Pentapharm Holding, and his management team started years ago. In addition, the Pentapharm name will continue to exist.
Pentapharm expects few changes in terms of tradenames, management style, products, Swiss production, image and relationship. For more information, visit www.pentapharm.com.